14 January 2020
Internal scar tissue emerges relatively frequently following abdominal surgery. Such ‘adhesions’ can have far-reaching consequences. In a 2013 article in British Medical Journal, the surgical resident Richard ten Broek presented an overview of the most important complications (e.g., acute ileus, chronic pain, intestinal injuries from repeat surgeries, and decreased fertility). Adhesions thus constitute a serious medical problem.
The first large-scale study on adhesions (the SCAR study) was conducted in 1999, in which all patients in Scotland who had undergone abdominal surgery were followed. Of these patients, 5% were re-admitted in subsequent years due to complications that were definitely caused by adhesions. In addition, one third of all patients were re-admitted for complaints that were possibly consistent with complications from adhesions.
Fewer adhesions due to keyhole surgery
“The SCAR study was a catalyst for anti-adhesion drugs,” notes ten Broek from Radboudumc, “but most of these drugs were suitable for open surgery, which involves actually opening up the abdomen. At the time that these drugs were introduced, surgeons were increasingly shifting to laparoscopy—to minimally invasive keyhole operations.”
Although it was assumed that keyhole operations would result in fewer adhesions, it would be a long time before we could know the exact reduction in the number of adhesions or whether such techniques also led to other complications. Ten Broek: “In a recent publication, the ten Broek/van Goor research group demonstrates that, following open surgery, adhesions occur in nearly 90% of all patients. After laparoscopy, the number is about 70%. In addition, the adhesions occurring with open surgery are often more extensive, particularly in the direction of the abdominal wall.”
Fewer, but still too many
To improve the comparability of figures, ten Broek and his colleagues re-used the data from the Scottish databank to investigate re-admissions. This SCAR update, which was published in The Lancet, indicates that keyhole surgery reduces the risk of re-admissions due to adhesions. This reduction was 30% for re-admissions that were definitely due to adhesions, and 10% for complications that might have been associated with adhesions.
This seems to be good news. “Absolutely”, states ten Broek, “any decrease in the number of adhesions is more than welcome. Nevertheless, the total disease burden is still high. Too high. Of all patients who have had surgery, 4.7% are still re-admitted for complications due to adhesions, and about 30% are re-admitted for complications that might be associated with adhesions. In 1999, the total disease burden was virtually the same (re-admission rates of 5% and more than 30%, respectively). The risk of complications within certain groups (e.g., surgery on the large intestine or gynecological procedures) also remains high, even for keyhole operations. Although keyhole surgery has reduced the risk of adhesions, the disease burden for adhesions is still too high, even for laparoscopy. We must continue working to reduce these risks even further, while increasing the use of anti-adhesion drugs.”
Publicatie in The Lancet
Adhesion-related readmissions after open and laparoscopic surgery: a retrospective cohort study (SCAR update) - Pepijn Krielen, Martijn W J Stommel, Pille Pargmae, Nicole D Bouvy, Erica A Bakkum, Harold Ellis, Michael C Parker, Ewen A Griffiths, Harry van Goor, Richard P G ten Broek
Internal scar tissue emerges relatively frequently following abdominal surgery. Such ‘adhesions’ can have far-reaching consequences. In a 2013 article in British Medical Journal, the surgical resident Richard ten Broek presented an overview of the most important complications (e.g., acute ileus, chronic pain, intestinal injuries from repeat surgeries, and decreased fertility). Adhesions thus constitute a serious medical problem.
The first large-scale study on adhesions (the SCAR study) was conducted in 1999, in which all patients in Scotland who had undergone abdominal surgery were followed. Of these patients, 5% were re-admitted in subsequent years due to complications that were definitely caused by adhesions. In addition, one third of all patients were re-admitted for complaints that were possibly consistent with complications from adhesions.
Fewer adhesions due to keyhole surgery
“The SCAR study was a catalyst for anti-adhesion drugs,” notes ten Broek from Radboudumc, “but most of these drugs were suitable for open surgery, which involves actually opening up the abdomen. At the time that these drugs were introduced, surgeons were increasingly shifting to laparoscopy—to minimally invasive keyhole operations.”
Although it was assumed that keyhole operations would result in fewer adhesions, it would be a long time before we could know the exact reduction in the number of adhesions or whether such techniques also led to other complications. Ten Broek: “In a recent publication, the ten Broek/van Goor research group demonstrates that, following open surgery, adhesions occur in nearly 90% of all patients. After laparoscopy, the number is about 70%. In addition, the adhesions occurring with open surgery are often more extensive, particularly in the direction of the abdominal wall.”
Fewer, but still too many
To improve the comparability of figures, ten Broek and his colleagues re-used the data from the Scottish databank to investigate re-admissions. This SCAR update, which was published in The Lancet, indicates that keyhole surgery reduces the risk of re-admissions due to adhesions. This reduction was 30% for re-admissions that were definitely due to adhesions, and 10% for complications that might have been associated with adhesions.
This seems to be good news. “Absolutely”, states ten Broek, “any decrease in the number of adhesions is more than welcome. Nevertheless, the total disease burden is still high. Too high. Of all patients who have had surgery, 4.7% are still re-admitted for complications due to adhesions, and about 30% are re-admitted for complications that might be associated with adhesions. In 1999, the total disease burden was virtually the same (re-admission rates of 5% and more than 30%, respectively). The risk of complications within certain groups (e.g., surgery on the large intestine or gynecological procedures) also remains high, even for keyhole operations. Although keyhole surgery has reduced the risk of adhesions, the disease burden for adhesions is still too high, even for laparoscopy. We must continue working to reduce these risks even further, while increasing the use of anti-adhesion drugs.”
Publicatie in The Lancet
Adhesion-related readmissions after open and laparoscopic surgery: a retrospective cohort study (SCAR update) - Pepijn Krielen, Martijn W J Stommel, Pille Pargmae, Nicole D Bouvy, Erica A Bakkum, Harold Ellis, Michael C Parker, Ewen A Griffiths, Harry van Goor, Richard P G ten Broek
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Increased role of patients after bowel cancer treatment
30 July 2020 Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer. read more
Secure trial usual care to a restrictive patient selection for gallbladder surgery
23 May 2019 In Lancet Kees van Laarhoven and colleagues showed that usual care for gallstone patients is suboptimal and that less than two third of patients are pain-free after surgery. read more
Valentine’s day spectacle at the Radboud Research Rounds
21 February 2019 This year’s Valentine’s day in the Radboudumc was focused on the RRR of the Tumors of the Digestive Tract. In the biannual Paper Award session the big prize went to Daniel Garza from the Center for Molecular and Biomolecular Informatics, for his paper on “the environmental metabolome”. read more
Radiotherapy-associated angiosarcoma after breast cancer treatment
7 February 2019 In Jama Oncology Anouk Rombouts and co-workers showed that one in 1000 patients who were treated with radiotherapy for breast cancer will develop an angiosarcoma of the breast. read more
Remote patient follow up after colorectal cancer surgery
7 February 2019 Seyed Qaderi, Hans de Wilt and colleagues developed and implemented a new patient centered follow up schedule for colorectal cancer survivors. read more